These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28212710)

  • 21. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity].
    Komshilova KA; Troshina EA; Ershova EV; Mazurina NV; Platonova NM
    Ter Arkh; 2014; 86(10):27-32. PubMed ID: 25509888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and sphingolipids.
    Ye JJ; Bian X; Lim J; Medzhitov R
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17381-17388. PubMed ID: 32632018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease.
    Yang J; Guan Y
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():105-11. PubMed ID: 23855304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease].
    Yang H; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Hong Y
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):525-8. PubMed ID: 17669243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
    Park SH
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S34-9. PubMed ID: 20037278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
    Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
    Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.
    Xu X; Lu L; Dong Q; Li X; Zhang N; Xin Y; Xuan S
    Lipids Health Dis; 2015 Dec; 14():158. PubMed ID: 26631018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTRP family: linking immunity to metabolism.
    Schäffler A; Buechler C
    Trends Endocrinol Metab; 2012 Apr; 23(4):194-204. PubMed ID: 22261190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
    Pan MH; Lai CS; Tsai ML; Ho CT
    Mol Nutr Food Res; 2014 Jan; 58(1):147-71. PubMed ID: 24302567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study.
    Majidi Z; Emamgholipour S; Omidifar A; Rahmani Fard S; Poustchi H; Shanaki M
    Diabetol Metab Syndr; 2021 Jan; 13(1):14. PubMed ID: 33499897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
    Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
    World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease as a multi-systemic disease.
    Fotbolcu H; Zorlu E
    World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.